COMPARING THE RESPONSIVENESS OF TWO HEALTH-RELATED QUALITY OF LIFE INSTRUMENTS IN A PHASE III RANDOMIZED CLINICAL TRIAL OF MEN WITH PROSTATE CANCER (NCIC CTG PR.3): THE EORTC QLQ-C30+3 WITH PR17 TRIAL SPECIFIC CHECKLIST VERSUS THE FACT-P